Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Björn Wikström"'
Autor:
Francis Verbeke, Raymond Vanholder, Pieter L. Rensma, Björn Wikström, Per Bruno Jensen, Jean-Marie Krzesinski, Merete Rasmussen, Wim Van Biesen, Eero Honkanen
Publikováno v:
Artery Research, Vol 4, Iss 3 (2010)
Background: Accurate cardiovascular risk estimation in dialysis patients remains challenging because different pathogenetic mechanisms act simultaneously in this heterogeneous population. Radiographic calcification, aortic stiffness and wave reflecti
Externí odkaz:
https://doaj.org/article/116a5f46ed9d48b8a6e7dc122f70209e
Autor:
Lajos Major, Andreas Bock, Bernard Canaud, Klara Berta, Ralf Wojke, Enisa Mesic, Björn Wikström, Lajos Vaslaki
Publikováno v:
Hemodialysis International. 15:522-529
Cost reduction and quality improvement seem to be conflicting issues. However, online hemodiafiltration (oHDF) with new automatic functions offers a cost-efficient therapy compared to hemodialysis (HD). Seven dialysis centers conducted a randomized c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7614213992136d61381d812f229946e
https://doi.org/10.1111/j.1542-4758.2011.00577.x
https://doi.org/10.1111/j.1542-4758.2011.00577.x
Publikováno v:
Journal of Nursing and Healthcare of Chronic Illness. 3:87-98
Aim. To describe and perform a tailored treatment programme based on a behavioural medicine approach to enhance haemodialysis patients’ self-management of fluid restriction.Background. Haemodialy ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12f94c19c207fd055d00d08814741981
https://doi.org/10.1111/j.1752-9824.2011.01093.x
https://doi.org/10.1111/j.1752-9824.2011.01093.x
Autor:
Lars L. Thomsen, Jan Wilske, Björn Wikström, Peter Bárány, Philip A. Kalra, Søren Ladefoged, Sunil Bhandari
Publikováno v:
Journal of Nephrology. 24:589-596
Background: Patients with chronic kidney disease (CKD) often suffer from iron deficiency anemia necessitating treatment with intravenous iron. This study was designed to assess the safety of iron isomaltoside 1000 (Monofer) in CKD patients. The secon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f12403f35b8492eaafd653fa28f1732
https://doi.org/10.5301/jn.2011.6248
https://doi.org/10.5301/jn.2011.6248
Publikováno v:
Journal of Clinical Nursing. 19:2997-3005
This thesis is comprised of four studies and concerns haemodialysis patients’ confidence in being able to manage fluid intake between treatment sessions, and whether the fluid intake is influenced by certain modifiable characteristics of the person
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bef55b449a930fc5466d8eee72831647
https://doi.org/10.1111/j.1365-2702.2010.03372.x
https://doi.org/10.1111/j.1365-2702.2010.03372.x
Publikováno v:
Nephrology Dialysis Transplantation. 33:i315-i315
Administration of high doses (> 1000 Mg) of iron isomaltoside in chronic kidney disease patients with iron deficiency anaemia gives an effective increase in haemoglobin without additional safety concerns
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33e4f6bc9eeca6e492246d2a78ff8d40
https://doi.org/10.1093/ndt/gfy104.sao002
https://doi.org/10.1093/ndt/gfy104.sao002
Autor:
R. Pisoni, Margaret A. Eichleay, Björn Wikström, Jennifer L. Bragg-Gresham, Friedrich K. Port, Stefan H. Jacobson
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 44:113-120
Objective. To examine the association of adherence to Swedish Society of Nephrology guidelines on haemodialysis treatment and patient outcomes in Sweden. Material and methods. A prevalent cross-sectional sample of Swedish haemodialysis patients was o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc0ba8af84abe1ff852fb1a3d213b887
https://doi.org/10.3109/00365590903490047
https://doi.org/10.3109/00365590903490047
Autor:
Peter Bárány, Bengt Fellström, Björn Wikström, Anders Danielsson, Abdul Rashid Qureshi, Peter Stenvinkel, Juan Jesus Carrero, Olof Heimbürger, Ingela Fehrman-Ekholm, Sunna Snaedal, Anders Alvestrand
Publikováno v:
American Journal of Kidney Diseases. 53:1024-1033
Patients with chronic kidney disease stage 5 have high comorbidity and are prone to inflammation that may contribute to the high cardiovascular mortality risk.Three-month observational cohort study of prevalent hemodialysis patients.228 hemodialysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e64bf3fc9d300b1edae634a211580bdf
https://doi.org/10.1053/j.ajkd.2009.02.008
https://doi.org/10.1053/j.ajkd.2009.02.008
Autor:
Bo G. Danielson, Janusz Goch, Gunnar Birgegård, Björn Wikström, Jan E. Wahlberg, Soheir Beshara
Publikováno v:
European Journal of Haematology. 58:167-173
Ten patients, who received cadaveric kidneys, were followed for 24 wk with serial measurements of serum erythropoietin (S-Epo), transferrin receptor (S-TfR) and iron variables. The mean pretransplant creatinine clearance was 8.2 (range 0-22) ml/min a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3e43305686c94e6ee8a530044d5f67b
https://doi.org/10.1111/j.1600-0609.1997.tb00943.x
https://doi.org/10.1111/j.1600-0609.1997.tb00943.x
Autor:
M. Evergren, Pietra Molfettini, J. Audzijoniene, P. Centoni, J. Tomaz, Gösta Berlin, Björn Wikström, Rut Norda, K Mokvist, B. Nilsson Sojka, Giancarlo M. Liumbruno, Bernd Stegmayr, Volker Witt, C. G. Axelsson, W Ramlow, A. Griskevicius, Milan Bláha, J Ptak
Publikováno v:
Transfusion and apheresis science, 39(3), 255-260. PERGAMON-ELSEVIER SCIENCE LTD
Objectives: Paediatric patients are a special group in apheresis. It is general accepted to use adult indications in paediatric patients, but data in this age group are rare. In order to provide more information of apheresis practise in children and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be9051efb93af5e224356366bd0e16c2
https://doi.org/10.1016/j.transci.2008.09.001
https://doi.org/10.1016/j.transci.2008.09.001